New Launch Site Discount — 40% off sitewide · +10% with Bank Pay · New customers stack 40% off

Melanotan 2 (MT2)

From $50.00

Shop

Melanotan 2 (MT2) · Research brief

How Long Melatonin Stays in System — Clearance Timeline

58 WORDS

Short answer

Most people assume melatonin clears their system within an hour or two after taking it. But that's a misunderstanding of how half-life works. Melatonin's plasma half-life is 40–60 minutes, meaning half the dose is metabolized in that window. Full clearance. The point where more than 99% of the compound has been eliminated. Takes approximately 4–5 hours from ingestion.

Key takeaways

  • Melatonin has a plasma half-life of 40–60 minutes, but full clearance (>97% elimination) takes 4–5 hours from ingestion.
  • Hepatic metabolism via CYP1A2 is the rate-limiting step. Drugs or lifestyle factors that inhibit this enzyme (fluvoxamine, grapefruit juice) can extend clearance significantly.
  • Doses above 3mg saturate first-pass metabolism and extend clearance windows unpredictably, often into waking hours.
  • The primary urinary metabolite, 6-sulfatoxymelatonin, remains detectable for 12–16 hours and is used clinically to assess circadian phase.
  • Timing melatonin 5–6 hours before your target wake time prevents next-day grogginess and aligns with natural cortisol awakening response.
  • Elderly patients and those with impaired liver or kidney function clear melatonin 30–50% more slowly than healthy young adults.

Most people assume melatonin clears their system within an hour or two after taking it. But that's a misunderstanding of how half-life works. Melatonin's plasma half-life is 40–60 minutes, meaning half the dose is metabolized in that window. Full clearance. The point where more than 99% of the compound has been eliminated. Takes approximately 4–5 hours from ingestion. The confusion happens because 'half-life' doesn't mean 'gone in half the time.' It means the concentration halves repeatedly: 50% at 1 hour, 25% at 2 hours, 12.5% at 3 hours. The effect you feel and the presence of metabolites in your bloodstream are separate timelines.

We've worked with researchers who study peptide and hormone kinetics across hundreds of compounds, including melatonin analogs. The gap between pharmacokinetics (how long it's detectable) and pharmacodynamics (how long you feel it) is where most supplement timing mistakes happen.

How long does melatonin stay in your system after taking it?

Melatonin has a plasma half-life of approximately 40–60 minutes in healthy adults, meaning the body eliminates half the circulating dose within that timeframe. Full clearance. Defined as removal of 97–99% of the original dose. Occurs within 4–5 hours post-ingestion. The primary metabolic pathway involves hepatic hydroxylation via cytochrome P450 enzymes (CYP1A2), producing 6-sulfatoxymelatonin, which is excreted renally. Individual clearance rates vary based on liver enzyme activity, age, and concurrent medications that compete for CYP1A2 metabolism.

The Featured Snippet gives the standard clearance window, but it doesn't address why people experience residual grogginess or why melatonin taken at 11 PM still affects cortisol signaling at 7 AM. That's because the primary metabolite. 6-sulfatoxymelatonin. Remains detectable in urine for 12–16 hours, and while it's not pharmacologically active in the same way as melatonin itself, its presence indicates the sleep-wake signaling cascade has been activated. This article covers how melatonin's half-life translates to real-world clearance, what factors slow or accelerate elimination, and why timing your dose relative to your natural circadian peak matters more than most guides acknowledge.

What Determines How Long Melatonin Stays Active

Melatonin clearance is governed by hepatic metabolism. Specifically, the cytochrome P450 enzyme CYP1A2, which hydroxylates melatonin into 6-hydroxymelatonin before conjugation with sulfate or glucuronide for renal excretion. Anything that induces or inhibits CYP1A2 activity directly impacts clearance rate. Cigarette smoking, for example, induces CYP1A2 expression and accelerates melatonin metabolism by 30–40%, shortening the effective half-life. Conversely, fluvoxamine (an SSRI) is a potent CYP1A2 inhibitor that can extend melatonin half-life up to 17-fold, turning a standard 3mg dose into a prolonged exposure event.

Age is the second major variable. Melatonin clearance declines with age. A 70-year-old metabolizes melatonin approximately 50% more slowly than a 25-year-old with equivalent liver function, primarily due to reduced CYP1A2 activity and decreased renal filtration efficiency. This means elderly patients taking identical doses experience longer durations of circulating melatonin, which compounds the risk of next-day sedation and circadian phase shifts if dosed incorrectly.

Dose size scales linearly with clearance time up to a threshold. Beyond approximately 5mg, saturation of first-pass hepatic metabolism occurs, and clearance shifts from rapid enzymatic processing to slower diffusion-limited pathways. A 10mg dose doesn't take twice as long to clear as a 5mg dose; it takes closer to 2.5–3× longer because you've exceeded the liver's processing capacity. Most clinical sleep studies use 0.3–1mg for physiological replacement; doses above 3mg are supraphysiological and extend clearance windows unpredictably.

The Difference Between Half-Life and Full Clearance

Half-life measures the time required for plasma concentration to drop by 50%. Melatonin's is 40–60 minutes. Full clearance is defined by the point at which less than 3% of the original dose remains systemically, which occurs after approximately 5 half-lives. For melatonin, that's 200–300 minutes, or 3.3–5 hours. This is pharmacokinetic modeling. After 5 half-lives, 96.875% of the dose is eliminated, which clinically rounds to 'cleared.'

The mistake most users make: assuming 'half-life' means the drug is gone in that window. If you take 3mg melatonin at 10 PM, here's the actual clearance curve: 1.5mg remains at 11 PM, 0.75mg at midnight, 0.375mg at 1 AM, 0.19mg at 2 AM, 0.09mg at 3 AM. You're not fully clear until approximately 3 AM, even though the sedative peak occurred around 10:30–11 PM. The receptor-binding effects don't scale linearly with plasma concentration. MT1 and MT2 receptor saturation occurs at relatively low concentrations, so even residual melatonin can maintain signaling activity.

This is why melatonin dosed too late causes morning grogginess. You're waking with circulating melatonin still present, which suppresses cortisol awakening response and delays the shift from parasympathetic to sympathetic tone. For optimal use, dose melatonin 5–6 hours before your desired wake time, not just 'before bed.' If you wake at 6 AM, don't take melatonin after 12:30 AM.

Metabolism, Excretion, and What Remains Detectable

Melatonin undergoes Phase I metabolism (hydroxylation via CYP1A2) followed by Phase II conjugation (sulfation or glucuronidation). The primary urinary metabolite is 6-sulfatoxymelatonin, which remains detectable in urine for 12–16 hours post-dose. This is the marker used in circadian rhythm research to assess endogenous melatonin production timing. The metabolite itself is not pharmacologically active at melatonin receptors, but its prolonged presence indicates the hypothalamic-pituitary axis has been signaled.

Renal clearance accounts for more than 90% of melatonin elimination. Impaired kidney function extends systemic exposure significantly. Patients with chronic kidney disease (CKD stage 3 or higher) should use reduced doses or avoid supplemental melatonin entirely unless under medical supervision, as accumulation of both melatonin and its metabolites can occur.

What's rarely discussed: melatonin's lipophilicity allows it to cross the blood-brain barrier rapidly, but it also means adipose tissue can act as a secondary reservoir. In individuals with high body fat percentages, a small fraction of melatonin may partition into fat stores and be released slowly over hours, creating a tail-end clearance phase that standard pharmacokinetic models don't fully capture. This doesn't meaningfully extend plasma half-life but does contribute to variability in next-day effects.

How Long Melatonin Stays in System: Dose-Dependent Clearance Comparison

Dose Plasma Half-Life Estimated Full Clearance Time Peak Plasma Concentration (Approx.) Next-Day Residual Risk Professional Assessment
0.3–0.5mg (physiological) 40–50 minutes 3.5–4 hours 100–200 pg/mL Minimal. Clears before typical wake time Optimal for circadian entrainment without saturation
1–3mg (standard OTC) 50–60 minutes 4–5 hours 500–2000 pg/mL Low if dosed 6+ hours before wake Effective range for most users. Dose timing critical
5–10mg (supraphysiological) 60–90 minutes 5–7 hours 3000–8000 pg/mL Moderate to high. Metabolic saturation occurs Exceeds receptor capacity. Longer clearance, higher grogginess
10mg+ (high dose) 90–120 minutes 7–9 hours 8000+ pg/mL High. Likely morning sedation Unnecessary for sleep. Clearance extends into waking hours

The dose-response curve for melatonin is not linear. Receptor saturation occurs around 0.3–1mg; anything above that doesn't proportionally increase sleep quality but does increase clearance time and next-day effects. Most commercial melatonin products are dosed 10–30× higher than the physiological replacement level, which explains why 'melatonin hangovers' are common despite the short half-life.

What If: Melatonin Clearance Scenarios

What If I Take Melatonin at 2 AM and Need to Wake at 7 AM?

You'll wake with circulating melatonin still present. At a 3mg dose, approximately 0.2–0.4mg remains in your system at 7 AM (5 hours post-dose), which is enough to suppress cortisol awakening response and delay sympathetic activation. The result: grogginess, delayed alertness, and impaired morning cognitive performance. If you must dose late, reduce to 0.5mg or less. Or skip it entirely and rely on sleep hygiene alone.

What If I'm Taking Fluvoxamine or Another CYP1A2 Inhibitor?

Melatonin clearance can extend from 4–5 hours to 12+ hours when CYP1A2 is inhibited. Fluvoxamine increases melatonin exposure by 12–17-fold in clinical studies. If you're on an SSRI or other CYP1A2 inhibitor, start with 0.3mg melatonin maximum and monitor for prolonged sedation. Do not take standard 3–5mg doses. The combination creates functional overdosing even at physiological replacement levels.

What If I Smoke Cigarettes — Does That Change Melatonin Duration?

Yes. Cigarette smoking induces CYP1A2 expression, which accelerates melatonin clearance by 30–40%. Smokers metabolize melatonin faster than non-smokers, meaning a 3mg dose clears in closer to 3–3.5 hours instead of 4–5 hours. This doesn't mean you should increase your dose; it means your effective window is shorter. Dose timing becomes even more critical. Take it earlier relative to bedtime to align peak effect with sleep onset.

The Clinical Truth About Melatonin Clearance

Here's the honest answer: most people are taking melatonin wrong because they're chasing sedation instead of circadian alignment. Melatonin is not a sleeping pill. It's a chronobiotic signal that tells your hypothalamus 'nighttime is starting.' The receptor-mediated effect happens at concentrations far below what OTC supplements deliver. A 10mg melatonin gummy doesn't make you sleep 10× better than a 1mg dose; it just saturates your liver enzymes and keeps melatonin circulating into the next morning.

The clinical evidence is clear: 0.3–1mg dosed 5–6 hours before wake time outperforms 5–10mg dosed 'whenever you feel like sleeping' in almost every measurable outcome. Sleep latency, next-day alertness, circadian phase shift, and subjective sleep quality. The supplement industry sells high-dose melatonin because it feels like it's doing more; pharmacologically, it's doing less of what matters and more of what creates side effects.

If you're experiencing grogginess, dose-timing is the first variable to adjust. Not the milligram amount. Melatonin taken at the wrong circadian phase creates the problems it's supposed to solve.

Full metabolic clearance takes 4–5 hours for standard doses, but the signaling cascade melatonin initiates. Suppression of cortisol, activation of GABA-A pathways, modulation of core body temperature. Persists beyond plasma clearance. That's why timing the dose relative to your natural dim-light melatonin onset (DLMO) matters more than the absolute amount you take. Measure success by how you feel at wake-up, not by how sedated you feel at bedtime.

Questions

After taking 3mg melatonin, plasma half-life is approximately 50–60 minutes, meaning full clearance (>97% elimination) occurs within 4–5 hours. However, the primary urinary metabolite, 6-sulfatoxymelatonin, remains detectable for 12–16 hours. Next-day effects depend on timing — if dosed 6+ hours before waking, residual melatonin is minimal. If dosed within 5 hours of wake time, you may experience morning grogginess due to suppressed cortisol awakening response.
Standard drug tests (urine, blood, saliva) do not screen for melatonin — it is a naturally occurring hormone, not a controlled substance. The metabolite 6-sulfatoxymelatonin can be detected in research-grade assays for 12–16 hours post-dose, but this is used clinically to assess circadian rhythm timing, not for employment or legal screening. Melatonin supplementation will not trigger false positives on drug panels.
Taking melatonin within 4–5 hours of waking leaves circulating melatonin in your system during the cortisol awakening response, which normally peaks 30–45 minutes after waking. Residual melatonin suppresses this cortisol surge, delaying the transition from parasympathetic (rest) to sympathetic (alert) tone. The result is grogginess, impaired cognitive performance, and delayed alertness that can persist for 1–2 hours post-wake.
Yes — melatonin clearance declines approximately 30–50% in adults over 65 compared to younger adults, primarily due to reduced CYP1A2 enzyme activity and decreased renal filtration efficiency. Elderly patients metabolize melatonin more slowly, which increases the risk of next-day sedation and circadian phase shifts. Lower doses (0.3–1mg) are recommended for older adults to avoid prolonged systemic exposure.
Melatonin is primarily metabolized by hepatic CYP1A2 enzymes — impaired liver function reduces clearance rate significantly. Patients with cirrhosis or hepatic insufficiency may experience 2–3× longer clearance times, turning a 4-hour elimination window into 8–12 hours. Dose reduction is essential in hepatic impairment; starting doses should not exceed 0.5mg, and timing should account for extended duration.
Grogginess after melatonin clearance is usually due to circadian phase shifting rather than residual drug presence. Melatonin signals the hypothalamus to suppress cortisol and initiate sleep-phase hormonal cascades — these effects persist beyond plasma clearance because they’ve altered your circadian timing. If you dose melatonin too late or at the wrong phase of your natural rhythm, you create a mismatch between when your body thinks it should wake and when your alarm goes off.
Melatonin does not accumulate systemically with nightly use — it is fully metabolized and excreted within 4–5 hours, so there is no pharmacokinetic buildup. However, chronic exogenous melatonin supplementation can suppress endogenous production over time, a phenomenon called feedback inhibition. This doesn’t mean melatonin ‘stays in your system’ longer; it means your pineal gland may downregulate its own output if you rely on supplementation long-term.
Immediate-release melatonin delivers the full dose within 30 minutes, with peak plasma concentration at 60–90 minutes and clearance by 4–5 hours. Extended-release formulations delay absorption over 4–6 hours, maintaining lower plasma levels for longer but extending total clearance time to 6–8 hours. Extended-release is intended to mimic natural nocturnal melatonin secretion but increases next-day residual risk if dosed incorrectly.
Taking melatonin with food — especially high-fat meals — delays absorption by 30–60 minutes but does not significantly alter total clearance time. The half-life remains 40–60 minutes; the peak concentration is simply reached later. Fasting absorption is faster, which is why most clinical protocols recommend taking melatonin on an empty stomach 30–60 minutes before desired sleep onset.
Melatonin and its metabolites are excreted renally — chronic kidney disease (CKD stage 3 or higher) extends clearance time significantly, often by 50–100%. Patients with impaired renal function should use reduced doses (0.3–0.5mg maximum) and avoid nightly use without nephrologist oversight, as accumulation of 6-sulfatoxymelatonin can occur with repeated dosing.

RESEARCH USE ONLY · NOT EVALUATED BY THE FDA

Shop Now